Sonoma Pharmaceuticals shares are trading higher after the company entered an agreement with Dawson James Securities to sell 2,962,962 units at $1.35 per unit.

Benzinga Newsdesk www.benzinga.com Positive 94.9%

Neg 0% Neu 0% Pos 94.9%

Comments

No comments yet. Be the first!